No description available.

No description available.

No description available.

O objetivo do presente estudo foi avaliar as características físico-químicas, microbiológicas, índices de proteólise, lipólise e viscosidade do iogurte natural batido, elaborado a partir de leite integral contendo três níveis de células somáticas (CS): <400.000 células/mL, 400.000-800.000 células/mL e >800.000 células/mL. Cada tipo de leite foi obtido da ordenha de animais previamente selecionados de acordo com o nível de CS e a composição do leite. Para a fabricação do iogurte, o leite foi padronizado quanto ao teor de sólidos totais (ST) e transferido para tanque multi-uso, no qual foi submetido à pasteurização (90ºC, 15 minutos), seguida da adição da cultura starter, incubação (42ºC, aprox. 3 horas) e envase do produto. O iogurte foi mantido em câmara fria a 5ºC, sendo que os parâmetros de qualidade foram avaliados mediante a colheita de amostras nos dias 1, 10, 20 e 30 após a fabricação. A seqüência de elaboração foi repetida seis vezes, no período de março a agosto/2003. As análises efetuadas no produto incluíram: pH, acidez, percentuais de gordura, ST, sólidos não-gordurosos (SNG), nitrogênios total (NT), não caseinoso (NNC) e não protéico (NNP), ácidos graxos livres (AGL), viscosidade aparente, contagem de bactérias láticas e coliformes a 30º e 45ºC. Não foram constatadas diferenças (P > 0,05) entre os parâmetros físico-químicos e microbiológicos obtidos no leite e no iogurte. Os índices de proteólise dos iogurtes, estimados através da relação NT – NNC / NT – NNP, mantiveram-se constantes, não apresentando diferenças entre os tratamentos (P > 0,05). A viscosidade do iogurte produzido com leite contendo mais de 800.000 células/mL foi maior (P < 0,05) em relação aos outros tratamentos nos dias 10, 20 e 30 após a fabricação, observando-se uma correlação positiva (P < 0,05) com os níveis de CS no 10º e 20º dia de armazenamento. A concentração de AGL foi maior (P < 0,05) no iogurte de alta contagem de CS no 1º e 30º dia de armazenamento, sendo observada uma correlação positiva (P < 0,05) com o nível de CS nos mesmos dias. Os resultados indicam que o aumento dos níveis de CS no leite não apresenta efeitos sobre a proteólise do iogurte, porém origina um aumento na viscosidade e no grau de lipólise do produto durante o armazenamento por 30 dias. / The aim of the present study was to evaluate physical, chemical and microbiological characteristics, as well as proteolysis, lipolysis and viscosity of plain stirred yoghurt produced from whole milk with somatic cell counts (SCC) at levels of < 400,000 cells/mL, 400,000-800,000 cells/mL and > 800,000 cells/mL. Each milk treatment was obtained from selected cows, according to its SSC status and milk composition. Yoghurts were produced after standardisation of milk total solids (TS), followed by pasteurisation (90ºC, 15 minutes), addition of starter culture, incubation (42ºC, approx. 3 hours) and packaging. Yoghurts were stored at 5ºC, and quality evaluation was conducted in samples collected on days 1, 10, 20 and 30 after production. Manufacturing procedures were repeated for six times, from March to August/2003. Yoghurt analyses included: pH, acidity, fat, protein, TS, solids non-fat (SNF), total nitrogen (TN), non-casein nitrogen (NCN) and non-protein nitrogen (NPN), free fatty acids (FFA), apparent viscosity, lactic bacteria counts and coliforms at 30 and 45ºC. There were no differences (P > 0.05) in physical, chemical and microbiological parameters of milk and yoghurt among treatments. Proteolysis, as estimated by TN – NCN / TN – NPN relation, was constant for all treatment yoghurts (P > 0.05). Viscosity of high SCC yoghurt (> 800,00 cells/mL) increased (P < 0.05) on 10, 20 and 30 days storage, and a positive correlation (P < 0.05) with SCC was observed on days 20 and 30. FFA content was higher (P < 0.05) on days 1 and 30 of storage, and besides there was a positive correlation (P < 0.05) between SCC and FFA levels on the same days of storage. Results indicate that high SCC milk do not affect proteolysis of yoghurt, although it increases viscosity and lypolisis during storage for 30 days.

Rôle des récepteurs aux cannabinoïdes 1 (CB1R) du tissu adipeux sur la lipolyse et conséquences sur le métabolisme glucido-lipidique de la souris.L’obésité s’accompagne d’une dérégulation de la lipolyse responsable d’une libération excessive d’Acides Gras Libres (AGL) qui sont des acteurs majeurs dans la mise en place de la résistance périphérique à l’insuline. En parallèle, il est maintenant bien établi qu’au cours de l’obésité, une altération de l’activité du Système EndoCannabinoïde (SEC) dans plusieurs tissus métaboliques est observée. S’il est bien décrit que l’hyperactivation de ce système au sein du Tissu Adipeux (TA) favorise son expansion, les conséquences sur la lipolyse adipocytaire restent à déterminer.Ces travaux de thèse ont pour objectif principal de préciser le rôle du SEC dans la régulation de la lipolyse. Pour cela, l’AEA, un agoniste des récepteurs aux cannabinoïdes 1 (CB1R) et le JZL195, un inhibiteur des enzymes de dégradation des endocannabinoïdes, ont été utilisés in vivo chez la souris et in vitro sur un modèle d’explants pour augmenter le tonus endocannabinoïde dans le TA et en mesurer les conséquences sur l’activité lipolytique. Ensuite, les effets du blocage du SEC sur la lipolyse ont été étudiés chez la souris obèse par l’utilisation d’un antagoniste spécifique des CB1R, le Rimonabant.Ces travaux montrent que l’activation du SEC adipocytaire dans des conditions d’insulinémie élevée (période postprandiale) conduit à une altération du signal insulinique et à une perte de son effet antilipolytique favorisant le relargage d’AGL et pouvant, à terme, conduire à des effets délétères sur les tissus périphériques. A l’inverse, lorsque les voies de signalisation à l’insuline sont peu actives comme c’est le cas au cours du jeûne, la stimulation du SEC s’accompagne d’une activation de la voie PI3K/Akt freinant la lipolyse induite par le jeûne et favorisant ainsi le stockage des lipides et l’expansion du TA. Cette situation expérimentale est comparable à celle rencontrée au cours de l’obésité qui est associée à la fois, à une faible activité de la voie PI3K/Akt (résistance à l’insuline) et à une hyperactivation du SEC. Le blocage des CB1R par le Rimonabant chez la souris obèse, conduit à une stimulation importante de la lipolyse qui semble dépendre d’une activation de l’adénylate cyclase. Etant donné qu’un traitement par le Rimonabant s’accompagne également d’une augmentation du catabolisme des acides gras, il est raisonnable de penser que dans ces conditions, les AGL libérés n’exercent pas leurs effets délétères.En conclusion, ces travaux suggèrent que l’activation du SEC participe à l’installation d’une résistance à l’insuline dans le TA qui pourrait, à plus long terme, s’étendre aux tissus périphériques via les effets lipotoxiques des AGL issus de la lipolyse. Au cours de l’obésité, l’association d’une insulinorésistance et d’un tonus endocannabinoïde élevé favoriserait le stockage des lipides et l’expansion de la masse grasse. Au final, le blocage ciblé des CB1R du TA pourrait constituer une piste thérapeutique intéressante pour lutter contre les dérégulations métaboliques associées à l’obésité.Mots clés : Obésité, Insulinorésistance, Système Endocannabinoïde, Tissu Adipeux, Lipolyse, Métabolisme glucido-lipidique / Role of adipose tissue cannabinoid receptor 1 (CB1R) on lipolysis and consequences on lipid and carbohydrate metabolism in miceObesity is accompanied with lipolysis deregulation responsible for excessive Free Fatty Acid (FFA) release, which are key actors in the implementation of peripheral insulin resistance. In parallel, it is now well established that obesity is associated with EndoCannabinoid System (ECS) activity dysfunction in several metabolic tissues. If it is well described that overactivation of this system in the Adipose Tissue (AT) is favourable to its expansion, the consequences on lipolysis remain to be elucidated.The main objective of this thesis work was to precise the role of ECS on lipolysis regulation. To achieve this, AEA, a cannabinoid receptor 1 (CB1R) agonist and JZL195, an inhibitor of the enzymes responsible for the degradation of endocannabinoids, were used, in vivo in mice and in vitro on an explant model, to increase the endocannabinoid tone in the AT and analyse the consequences on lipolytic activity. Then, ECS blockade effect on lipolysis was studied in obese mice by using a specific CB1R antagonist, Rimonabant.This work demonstrates that activation of ECS under high insulinemia condition (postprandial state) alters insulin signalling limiting its antilipolytic effect and increasing FFA release which can ultimately be deleterious for peripheral tissues. Conversely, when insulin signalling pathways are weakly activated, as it is the case during fasting, ECS activation comes with PI3K/Akt activation impeding fasting induced lipolysis and promoting lipid storage and AT expansion. This experimental situation resembles that encountered in obesity which is associated, both with low activity of PI3K/Akt pathway (insulin resistance) and ECS overactivation. CB1R blockade by Rimonabant in obese mice lead to a strong stimulation of lipolysis which seems to be dependent on adenylate cyclase activation. Considering that Rimonabant treatment was also reported to be associated with improved fatty acid catabolism, it can be advanced that FFA released in excess in these conditions, do not have deleterious effects.In conclusion, this work suggests that ECS activation is involved in the onset of AT insulin resistance which ultimately could indirectly affect peripheral tissues via lipolysis derived FFA lipotoxicity. During obesity, the association of insulin resistance and ECS tone elevation would promote lipid storage and AT expansion. Finally, AT CB1R specific blockade could constitute an interesting therapeutic target limiting metabolic deregulations linked to obesity.Key words: Obesity, Insulin Resistance, Endocannabinoid System, Adipose Tissue, Lipolysis, Lipid and carbohydrate metabolism

O ácido linoléico conjugado (CLA) é um ácido graxo poliinsaturado, encontrado nos produtos da alimentação. Estudos indicam que o CLA possui ações contra câncer, aterogênese e DM 2 e obesidade. O presente trabalho avaliou os efeitos da suplementação crônica com CLA em ratos Wistar machos e teve como objetivo investigar o desenvolvimento corporal e o perfil metabólico dos animais e dos adipócitos isolados do tecido adiposo branco periepididimal. Após quatro semanas de suplementação os animais apresentaram redução no ritmo de ganho de peso, acompanhado de redução da ingestão alimentar, redução da massa adiposa e do volume celular dos adipócitos. A menor incorporação dos substratos acetato e glicose em lipídeos, o aumento lipólise e diminuição da expressão do PPAR?, também contribuíram para menor adiposidade encontrada. A redução de massa adiposa foi acompanhada por resistência à insulina, elevados níveis de citocinas inflamatórias e desenvolvimento de esteatose hepática. Esses fatores estão relacionados com o desenvolvimento de síndrome lipodistrófica em animais. Portanto, a efetividade do CLA em reduzir massa adiposa foi comprovada no presente estudo, mas os efeitos devem ser considerados. / Conjugated linoleic acid (CLA) is a natural polyunsatured fatty acid found in many dietary sources. Animal studies demonstrated that CLA has properties against cancer, atherogenesis, diabetes and obesity. This work evaluated the effects with chronic CLA supplementation in young adults Wistar male rats for four weeks, aiming to investigate the possible changes in corporal development and metabolic profile as well as the effects in isolated adipocytes of periepidydimal white adipose tissue of these supplemented animals. We observed a reduction of the rhythym of body weight gain, followed by diminished food intake, regression of adipose mass, and also a reduction of adipocyte volume. The findings of low incorporation of acetate and glucose substrates into lipids, elevation on the lipolytic response and reduction of PPAR-gamma gene expression, also contributed to the lower adiposity. This reduction in adipose mass was followed by insulin resistance, high levels of inflammatory citokines and the development of hepatic steatosis, features related to the development of lipodystrophic syndrome. Therefore, this study demonstrated the CLA effect on reduction of adipose mass, although adverse effects associated with CLA chronic supplementation must be considered.

Thesis (M.Sc. (Dietetics))--North-West University, Potchefstroom Campus, 2005.

Obesity and specifically central obesity is related to insulin resistance, type 2 diabetes and other components of the so-called metabolic syndrome. The aim of this study was to elucidate the interplay between hormones, nutrients and adipose depots in normal and insulin-resistant fat cell metabolism. High levels of free fatty acids (FFAs) induce insulin resistance in muscle and liver in vivo. In the present study, rat adipocytes were treated with high physiological levels of oleic or palmitic acid in vitro for 4-24 h. This treatment had no effect on basal or insulin-stimulated glucose uptake capacity in these cells, neither did it affect the levels of the insulin signalling proteins; insulin receptor substrate (IRS)-1 or –2, phosphatidylinositol 3-kinase (PI3-K), protein kinase B (PKB) or glucose transporter (GLUT) 4, or the regulation of lipolysis rate. Visceral adiposity is considered to be more harmful than peripheral adiposity with respect to metabolic and cardiovascular complications. In adipose biopsies from subjects undergoing abdominal surgery, we found that glucose uptake capacity was elevated in omental as compared to subcutaneous adipocytes. The sensitivity (EC50) or maximum relative response to insulin, measured as % of basal, did however not differ between the depots. In women, subcutaneous adipocytes displayed a higher lipolysis rate following cAMP-stimulation than omental adipocytes, whereas there was a tendency towards the opposite in adipocytes from men. No differences were found between depots or sexes in the ability of insulin to inhibit lipolysis or in the levels of the lipolysis regulating proteins, i.e. protein kinase A (PKA), hormone sensitive lipase (HSL) and perilipin. Glucocorticoids, e.g. cortisol, exert pronounced insulin-antagonistic effects and are associated with redistribution of fat from peripheral to central fat depots in humans. Treatment of human subcutaneous and omental adipocytes in vitro, with the cortisol analogue dexamethasone, resulted in a dose dependent down-regulation of basal and insulin-stimulated glucose uptake capacity in omental, but not in subcutaneous cells. Concomitantly, the levels of IRS-1 and PKB were decreased only in omental adipocytes after dexamethasone treatment. The relative effect of insulin to stimulate glucose uptake was however not altered by dexamethasone treatment. The cAMP-stimulated lipolysis rate was elevated by dexamethasone treatment in cells from the subcutaneous depot in women and tended to be elevated in omental cells from men. No alterations however, were seen in the levels of the assessed lipolysis regulating proteins. Subcutaneous as well as omental fat cell size correlated negatively to insulin action in subcutaneous fat cells in vitro after adjusting for age, sex and body fat parameters in non-diabetic, but not in type 2 diabetic, subjects. Large subcutaneous fat cell size was strongly related to plasma leptin levels in non-diabetic and in type 2 diabetic subjects. We conclude that 1) adipocytes seem to be less vulnerable to elevated levels of fatty acids than muscle and liver cells, 2) the interactions between glucocorticoids and insulin in the regulation of glucose uptake differ between adipose depots, 3) depot specific hormonal lipolysis regulation differs between sexes and 4) fat cell size is related to insulin action in subcutaneous fat cells and to circulating levels of leptin.

Obesity is America’s fastest growing health threat. Although a primary health risk factor, obesity increases the probability of secondary health consequences such as stroke, diabetes mellitus and heart disease. Siberian hamsters offer a convenient model to study obesity, as they exhibit a photoperiod-driven reversal of obesity during the fall-winter months (i.e., short-days-SD). SD responses in the Siberian hamster, amongst others, include decreased adiposity and gonadal regression. The duration of the dark period is faithfully transmitted into a neuroendocrine melatonin (MEL) signal; that codes seasonal information. The brain communicates with body fat (white adipose tissue- WAT) via the sympathetic nervous system (SNS). The central MEL binding sites, however, necessary for the body fat/lipid mobilization responses during SDs are not precisely known, although melatonin receptor (MEL 1aR) mRNA has been co-localized with sympathetic outflow neurons of WAT in several forebrain areas. This dissertation aims to identify and to characterize the contribution of central sites that are important in seasonal responses in Siberian hamsters. Thus, I asked: Which specific brain sites are both sufficient and necessary to stimulate SD-like decreases in body, WAT and testes mass? Furthermore, I tested if SD-induced decreases in body fat mass are accompanied by increased energy expenditure, specifically brown adipose tissue (BAT) thermogenesis. It is hoped that the identification of brain sites and mechanisms involved in the effortless reversal of obesity in these animals can be applied to treatment opportunities of human obesity.

Background: The role of dietary calcium in weight management is gaining support in the nutrition research community. It has been hypothesized that high calcium diets protect against fat gain by creating a balance of lipolysis over lipogenesis in adipocytes (Zemel et al., 2000) and that a diet deficient in calcium is associated with higher body weight and that augmenting calcium intake may reduce weight and fat gain or enhance fat loss (Shapses et al., 2004). Objectives: A lack of baseline data on the physical, physiological and mental effects of obesity on urban African women was the motivation for the POWIRS (Profiles of Obese Women with Insulin Resistance Syndrome) study. The aim of the study was to assess the effects of obesity on health determinants of urban African and white women by comparing the lifestyle and risk factors for non-communicable diseases (NCDs) of lean, overweight and obese subjects. This led to a multi-disciplinary cross-sectional case-control study in which health determinants and health status, as well as the underlying mechanistic relationships between these factors were measured in a sample of African women volunteers. The study was repeated a year later, done in a sample of white women volunteers, POWIRS II. The effect of calcium intake on body composition was assessed during this study. Methods: One hundred and two apparently healthy urban African women, between the ages of 20 and 50 years participated in the first phase of this case-control cross-sectional survey. For a period of about three weeks, each afternoon ten subjects were to report at a Metabolic Unit Facility (consisting of 10 single bedrooms, 2 bathrooms, a living room and kitchen). Each subject received a "participant sheet" which guided them through the different research 'stations' where the various measurements were done. During the course of the evening demographic questionnaires were filled in and all anthropometric measurements were taken, except weight and height measurements. All participants received an identical light supper which excluded alcohol and caffeine at 20h00, went to sleep before 23h00 and fasted overnight. From 06h00 in the morning weight, height and blood pressure measurements were taken. After a fasting blood sample was taken, a two-hour glucose tolerance test commenced. Subjects received a breakfast and afterwards habitual dietary intake questionnaires were completed. Results: Mean total dietary calcium intake as significantly higher in white women (POWIRS II), with a mean intake 1053.8 mg per day, as opposed to a mean intake of 494.8 mg calcium per day in the blacks subjects (POWIRS I). Mean fat intake in the black subjects was 59.3 g per day, and in the white women 103.1 g per day. Thus the calcium:fat ratio in white women was higher than in black women (11.0 and 8.4 respectively). After adjustment for age and total dietary energy intake, significant negative correlations were found between dietary calcium intake and various variables, only in the white subjects. These were BMI (r=-0.255, p=0.01), percentage body fat (r=-0.252, p=0.01), fasting insulin (r=-0.205, p=0.05) and fasting glucose (r=-0.199, p=0.046). The calcium:fat ratio correlated negatively with BMI (r=-0.378, p<0.0001), percentage body fat (r=-0.401, p<0.0001), fasting glucose (r=-0.229, p=0.02), fasting insulin (r=-0.212, p=0.04) and plasma leptin (r=-0.284, p=0.004). Adjustment for smoking resulted in slightly different correlation coefficients, but similar significant correlations were still found. The only significant association that was found in the black population, was a negative correlation between dietary calcium intake and systolic blood pressure (p=0.03) as well as diastolic blood pressure (p=0.04). After adjustment for age, smoking and dietary energy intake no significant correlations were found in the black subjects. Conclusion: The results from the POWIRS study in white women are consistent with the hypothesis that there may be an inverse relationship between adiposity and calcium intake. In our study higher calcium intakes were associated with lower body fat, lower BMI, lower fasting glucose and insulin, as well as plasma leptin in white women. The association seems to be significant in subjects with high intakes of fat and calcium (as seen in the white women). / Thesis (M.Sc. (Dietetics))--North-West University, Potchefstroom Campus, 2005.